Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 13/20 | 0.57 |
| ▸ | PGR | P06401 | 4/20 | 0.57 |
| ▸ | NR3C1 | P04150 | 6/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.55 |
| ▸ | SERPINA6 | P08185 | 3/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.55 |
| ▸ | AR | P10275 | 2/20 | 0.55 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.55 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.55 |
| ▸ | TNF | P01375 | 1/20 | 0.55 |
| ▸ | IL6 | P05231 | 1/20 | 0.55 |
| ▸ | GLUL | P15104 | 1/20 | 0.55 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.55 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11496812 | 0.99 | HIF1A (0.57) | HIF1APGRNR3C1HSD17B10SERPINA6 | |
| SCHEMBL1761169 | 0.92 | HIF1A (0.57) | HIF1APGRNR3C1HSD17B10SERPINA6 | |
| Phosphoric Acid SCHEMBL5501494 | 0.89 | NR3C1 (0.67) | HIF1APGRNR3C1HSD17B10SERPINA6 | |
| SCHEMBL13232 | 0.88 | HIF1A (0.74) | HIF1APGRNR3C1HSD17B10SERPINA6 | |
| SCHEMBL10700873 | 0.88 | HIF1A (0.64) | HIF1APGRNR3C1HSD17B10SERPINA6 | |
| SCHEMBL2299293 | 0.87 | HIF1A (0.72) | HIF1APGRNR3C1HSD17B10SERPINA6 | |
| SCHEMBL1512721 | 0.87 | HIF1A (0.72) | HIF1APGRNR3C1HSD17B10SERPINA6 | |
| SCHEMBL13270299 | 0.87 | HIF1A (0.72) | HIF1APGRNR3C1HSD17B10SERPINA6 | |
| Phosphoric Acid SCHEMBL1929804 | 0.86 | NR3C1 (0.64) | HIF1APGRNR3C1HSD17B10SERPINA6 | |
| SCHEMBL10527431 | 0.86 | HIF1A (0.62) | HIF1APGRNR3C1HSD17B10SERPINA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12145951-B2 | Inorganic-organic hybrid compounds including organic platinum-containing anions, for use in medicine | KARLSRUHER INSTITUT FUR TECHNOLOGIE (DE) | 2024-11-19 | — | — | US | claimed |
| US-20210292353-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2021-09-23 | — | — | US | claimed |
| EP-3829565-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2021-06-09 | — | — | EP | claimed |
| WO-2020025488-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2020-02-06 | — | — | WO | claimed |
| CN-105997845-B | A kind of application of methylprednisolone sustained-release gel and preparation method and the gel in prevention Failed Back Surgery Syndrome | 西安交通大学 | 2019-04-09 | — | — | CN | claimed |
| US-20170112948-A1 | Inorganic-organic hybrid compound | Karlsruher Institut für Technologie (DE) | 2017-04-27 | — | — | US | claimed |
| EP-3122756-A1 | INORGANIC-ORGANIC HYBRID COMPOUND | Karlsruher Institut für Technologie (DE) | 2017-02-01 | — | — | EP | claimed |
| CN-105997845-A | Methylprednisolone controlled-release gel, preparing method and application of gel to lumbar surgery failure syndrome prevention | 西安交通大学 | 2016-10-12 | — | — | CN | claimed |
| EP-1744683-B1 | APPARATUS AND METHOD FOR TRANSDERMAL DELIVERY OF PARATHYROID HORMONE AGENTS | ALZA CORP (US) | 2016-03-16 | — | — | EP | claimed |
| WO-2015144282-A1 | INORGANIC-ORGANIC HYBRID COMPOUND | Karlsruher Institut für Technologie (DE) | 2015-10-01 | — | — | WO | claimed |
| WO-2002040029-A2 | CORTICOSTEROIDS ADDUCTS WITH NATURAL POLYSACCHARIDE POLYMERS | PHARMA BIOTECH LIMITED (CY) | 2002-05-23 | — | — | WO | claimed |
| US-20240423907-A1 | Improved Nasal Administration of Pharmaceutical Formulations | CYRANO THERAPEUTICS, INC. | 2024-12-26 | — | — | US | disclosed |
| CN-119012999-A | Improved nasal administration of pharmaceutical formulations | 思瑞诺医疗有限公司 | 2024-11-22 | — | — | CN | disclosed |
| US-12145951-B2 | Inorganic-organic hybrid compounds including organic platinum-containing anions, for use in medicine | KARLSRUHER INSTITUT FUR TECHNOLOGIE (DE) | 2024-11-19 | — | — | US | disclosed |
| EP-4460284-A1 | IMPROVED NASAL ADMINISTRATION OF PHARMACEUTICAL FORMULATIONS | Cyrano Therapeutics, Inc. (US) | 2024-11-13 | — | — | EP | disclosed |
| EP-1131054-A2 | METHODS FOR PREPARING COATED DRUG PARTICLES AND PHARMACEUTICAL FORMULATIONS THEREOF | UNIVERSITY OF FLORIDA (US) | 2001-09-12 | — | — | EP | disclosed |
| US-6264917-B1 | MIXTURE OF GAS FILLED MICROBUBBLES AND RELEASING AGENT | NYCOMED IMAGING AS (NO) | 2001-07-24 | — | — | US | disclosed |
| US-6261537-B1 | TARGETS AND ULTRASOUND DIAGNOSIS OF ACTIVE MATERIALS, AQUEOUS CARRIER LIQUIDS, CARRIERS AND FILM FORMING SURFACTANT PHOSPHATIDES | NYCOMED IMAGING AS (NO) | 2001-07-17 | — | — | US | disclosed |
| WO-2000028969-A2 | METHODS FOR PREPARING COATED DRUG PARTICLES AND PHARMACEUTICAL FORMULATIONS THEREOF | UNIVERSITY OF FLORIDA (US) | 2000-05-25 | — | — | WO | disclosed |
| EP-0106115-A2 | Process for the purification of alkaline salts of corticosteroid-phosphoric-acid esters and their utilization | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-04-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170112948-A1 | Inorganic-organic hybrid compound | SLCO4C1, SLCO2A1, SLCO1A2 | HIF1A 4074/4885PGR 1842/4885NR3C1 3107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.